NU Skin Enterprises Inc (NUS) is not a good buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The technical indicators are bearish, financial performance is weak, and there are no positive catalysts or strong trading signals to support a buy decision.

Technical Analysis

The stock is showing bearish technical indicators. The MACD histogram is negative and contracting (-0.106), RSI is at 35.172 (neutral but leaning towards oversold), and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 8.271), with resistance levels at R1: 9.914 and R2: 10.421.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

The options data suggests a bearish sentiment with a high put-call volume ratio of 61.0, indicating more puts being traded compared to calls.

Technical Summary

Sell

Buy

Positive Catalysts

NULL identified. No recent news, no significant hedge fund or insider activity, and no recent congress trading data.

Neutral/Negative Catalysts

Weak financial performance in Q4 2025 with revenue down -16.89% YoY, net income down -140.14% YoY, and EPS down -139.73% YoY. Additionally, the options data and technical indicators suggest bearish sentiment.

Financial Performance

In Q4 2025, the company's revenue dropped to $370.32M (-16.89% YoY), net income fell to $14.49M (-140.14% YoY), and EPS declined to $0.29 (-139.73% YoY). Gross margin increased to 70.74% (+12.91% YoY), but this improvement is overshadowed by the significant declines in other financial metrics.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast NUS stock price to rise

Buy

Hold

Sell

Current: 8.480

Low

Averages

High